Evidence map›Paper›PMID 41195598›Full record

ReviewInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026

Fibroids and pregnancy.

Diana Ramasauskaite, Nikhil Purandare, Ivonne Diaz, Greta Kvederaite-Budre, Titus K Beyuo, Jolly Beyeza-Kashesya, Bo Jacobsson

Abstract readReview
In one paragraph

Review in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. From prevalence to precision: Integrating phenotype, symptoms, reproductive goals, and treatment in leiomyoma care.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Contemporary Management of Uterine Fibroids.Journal of clinical medicine · 2026
    Review
  6. Fibroids and pregnancy.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diana RamasauskaiteClinic of Obstetrics and Gynecology, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Nikhil PurandareDepartment of Obstetrics and Gynaecology, University College Hospital Galway, University of Galway, Galway, Ireland.
Ivonne DiazDepartment of Obstetrics and Gynecology, Nueva Granada and Unisanitas University, Bogotá, Colombia.
Greta Kvederaite-BudreClinic of Obstetrics and Gynecology, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Titus K BeyuoDepartment of Obstetrics and Gynaecology, University of Ghana Medical School, Accra, Ghana.
Jolly Beyeza-KashesyaDepartment of Obstetrics and Gynecology, Mulago Specialised Women and Neonatal Hospital, Kampala, Uganda.
Bo JacobssonDepartment of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of uterine fibroids in pregnancy varies between 1.6% and 10.7%. Pregnancies involving uterine fibroids are generally uncomplicated. However, complications can occur, particularly in cases of multiple fibroids, when the fibroids are larger than 5 cm, or when they are located in the lower uterine segment. Between 10% and 30% of pregnant women with fibroids experience complications during pregnancy, labor, and the postpartum period. The most common complication during pregnancy, which can occur in 8% of women, is red degeneration. High-quality data on the relationship between fibroids and pregnancy outcome are very limited. Potential obstetric complications include preterm birth (increased risk, OR 1.5; 95% CI, 1.3-1.7), malpresentation of the baby (OR 2.65; 95% CI, 1.60-3.70), placental abruption (OR 2.63; 95% CI, 1.38-3.88), placenta previa (OR 2.21; 95% CI, 1.48-2.94), cesarean birth (OR 2.60; 95% CI, 2.02-3.18), postpartum hemorrhage (OR 2.95; 95% CI, 1.86-4.66), and other rare occurrences. Most women with uterine fibroids are able to deliver vaginally without complications. Cesarean birth is typically performed for standard obstetric indications. It is recommended that cesarean myomectomy should be avoided when possible.

Indexed as

LeiomyomaPregnancy Complications, NeoplasticUterine NeoplasmsCesarean SectionFemaleHumansPostpartum HemorrhagePregnancyPregnancy OutcomePremature Birthcomplicationsfibroidsleiomyomamanagementpregnancy

Identifiers

PMID41195598
PMCPMC12724024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.